IL-33 Antikörper (AA 150-200)
Kurzübersicht für IL-33 Antikörper (AA 150-200) (ABIN6990277)
Target
Alle IL-33 (IL33) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 150-200
-
Aufreinigung
- IL-33 Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- Anti-IL-33 antibody was raised against a 17 amino acid synthetic peptide from near the center of human IL-33. The immunogen is located within the 150-200 amino acids of IL-33.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1-2 μ,g/mL, IF: 20 μ,g/mL, IHC-P: 2.5 μ,g/mL.
Antibody validated: Western Blot in human and mouse samples, Immunofluorescence and Immunohistochemistry in human samples. All other applications and species not yet tested. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- IL-33 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,4 °C
-
Informationen zur Lagerung
- IL-33 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- IL-33 (IL33) (Interleukin 33 (IL33))
-
Andere Bezeichnung
- IL-33
-
Hintergrund
- IL-33 Antibody: Interleukin-33 (IL-33) is a recently identified member of the IL-1 family of cytokines whose other members include IL-1α,/beta, IL-1Ra and IL-18. Its receptor has been shown to be ST2, an IL-1 receptor family member that also acts as a negative regulator of TLR-IL-1R signaling and IL-1R accessory protein (IL-1RAcP). Receptor binding of IL-33 activates NF-κ,B and MAP kinases and induces the expression of TH2-associated cytokines such as IL-4, IL-5 and IL-6. Prolonged IL-33 treatment of mice led to the development of eosinophilia, splenomegaly, and severe pathological changes in mucosal organs such as lungs, esophagus and small intestine. Recent experiments have shown that IL-33 can also co-localize with heterochromatin and possesses transcriptional repressor activities, indicating that IL-33 may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.
-
Molekulargewicht
-
Predicted: 31kD
Observed: 33kD kDa -
Gen-ID
- 90865
-
NCBI Accession
- NP_254274
-
UniProt
- O95760
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-